Brenner West Capital Advisors - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Brenner West Capital Advisors ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$20,249,000
-0.5%
1,011,431
+28.4%
2.52%
+10.5%
Q2 2018$20,347,000
-10.1%
787,723
-16.8%
2.28%
-26.3%
Q1 2018$22,633,000
-47.4%
947,006
-25.4%
3.09%
-45.1%
Q4 2017$43,044,000
+19.5%
1,270,123
-25.4%
5.64%
+31.0%
Q3 2017$36,020,000
+45.0%
1,701,477
+19.8%
4.30%
+48.9%
Q2 2017$24,839,000
+19.1%
1,420,156
+19.2%
2.89%
+37.4%
Q1 2017$20,847,000
+1.0%
1,191,282
-2.5%
2.10%
-7.7%
Q4 2016$20,643,000
+7.6%
1,221,463
+4.5%
2.28%
+32.9%
Q3 2016$19,188,000
+24.6%
1,169,275
+15.0%
1.72%
+28.0%
Q2 2016$15,397,000
+96.0%
1,017,000
+87.2%
1.34%
+116.8%
Q1 2016$7,855,000543,2380.62%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders